Resveratrol |
NCT04266353 |
Effect of Resveratrol on Serum IGF2
in African American Women |
Participants will be given 150 mg of
resveratrol per day for six weeks |
Ginseng |
NCT00631852 |
A Phase II Biomarker Trial of Gelatin
Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer |
American ginseng extract from the roots was administered as follows:
four 250 mg tablets were taken daily for five to fourteen days prior to
surgery |
Artemisimin
(Artesunate)
|
NCT00764036
|
Patients with metastatic or locally advanced breast cancer are being
studied in a prospective open uncontrolled phase I study to determine
the compatibility, safety, and pharmacokinetics of the semi-synthetic
artemisinin derivative artesunate from the Chinese herb artemisia
annua
|
The medication was given orally once day for four weeks in dosages of
100, 150, or 200 mg of artesunate.
|
EGCG |
NCT00917735 |
Study of the Green Tea Extract’s Efficacy
on Breast Cancer Risk Biomarkers in High-Risk Women With Different
Catechol-O-Methyl Transferase (COMT) Genotypes under Placebo Control |
Two green tea extract capsules containing 51.7% EGCG should be taken
orally twice day, after breakfast and supper, for a period of one
year. |
Curcumin |
NCT03980509 |
Curcumin, the active ingredient in
turmeric, in a ”Window Trial” for primary invasive breast cancer tumors |
From the time surgical resection is scheduled until the night before
surgical resection, 500 mg of curcumin will be given orally twice daily,
after each meal |